2020
An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic
Jamwal S, Gautam A, Elsworth J, Kumar M, Chawla R, Kumar P. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic. Life Sciences 2020, 257: 118105. PMID: 32687917, PMCID: PMC7366108, DOI: 10.1016/j.lfs.2020.118105.Peer-Reviewed Original ResearchConceptsCOVID-19 patientsSARS-CoV-2Secondary complicationsPathogenic SARS-CoV-2Hospitalized COVID-19 patientsRecovered COVID-19 patientsCOVID-19Brief clinical updatesNew SARS-CoV-2 virusCOVID-19 pathogenesisACE-2Broad-spectrum antiviral drugsCOVID-19 infectionCoronavirus disease 2019Vaccines/drugsSARS-CoV-2 virusHepatic complicationsViral burdenConvalescent plasmaClinical updateAngiotensin IIImmune damageEpidemiological featuresClinical trialsDisease 2019
2017
Animal Models of Epilepsy
Koshal P, Jamwal S, Akula K, Bansal P. Animal Models of Epilepsy. 2017, 59-78. DOI: 10.1007/978-981-10-5981-0_5.Peer-Reviewed Original ResearchCentral nervous systemAntiepileptic drugsEpileptic seizuresPrinciple inhibitory neurotransmitterDevelopment of epilepsyLong-term outcomesType of epilepsyExcessive electrical dischargesGABAergic axon terminalsTreatment of epilepsyCommon neurological disorderPopulations of neuronsAmino butyric acidFrequent seizuresGABAB receptorsSecondary complicationsInhibitory neurotransmitterGABAA receptorsMotor disordersAxon terminalsEpileptic patientsHealthcare costsAnimal modelsNervous systemNeonatal stage